EUVIMEDEUVIMED entdecken
Übersichtsarbeit

SOHO State of the Art Updates and Next Questions | Success of a Modified Adolescent and Young Adult Treatment for Acute Lymphoblastic Leukemia in Mexico

Juan Luis Ontiveros, Roberta Demichelis-Gómez

Clinical Lymphoma Myeloma and Leukemia · 2026

DOI: 10.1016/j.clml.2025.10.012 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2026. Verfasst von Juan Luis Ontiveros und 1 weiteren Autor:innen. Beteiligte Einrichtung: Hematology and Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute lymphoblastic leukemia (ALL) incidence in Mexico and Central America is among the highest worldwide, with a significant proportion of cases occurring in adolescents and young adults (AYA). Historically, outcomes for Mexican adults with ALL have been poor, driven by high treatment-related mortality, limited access to specialized care and diagnostics, and a higher prevalence of adverse-risk genetic subtypes, including Philadelphia-like ALL. During the last decade, pediatric-inspired regimens (PIR) have transformed the management of AYA ALL globally, but their implementation in low- and middle-income countries poses unique challenges. We describe the adaptation and stepwise implementation of a modified CALGB 10403 (mCALGB) regimen in Mexico, replacing pegaspargase with native E. coli asparaginase and standardizing supportive care. Across six centers in Mexico and Guatemala, 95 patients treated with mCALGB achieved a complete remission rate of 87.8%, 2-year overall survival (OS) of 72.1%, and relapse rate of 28.3%, markedly improved compared with historical Mexican cohorts and approaching outcomes of the original CALGB 10403 trial. Similar results have been reproduced by other Latin American groups using BFM- or CALGB-based regimens. Key challenges remain, including higher rates of induction infections, metabolic toxicities linked to obesity and Hispanic ancestry, and major disparities in access to diagnostics and novel agents such as blinatumomab and CAR-T cells. Future priorities include national strategies to expand precision diagnostics, collaborative clinical research, and equitable implementation of innovative therapies. Pediatric-inspired regimens adapted to local resources represent a critical step toward closing the survival gap for Hispanic AYA patients with ALL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precursor Cell Lymphoblastic Leukemia-LymphomaAntineoplastic Combined Chemotherapy ProtocolsHumansMexicoAdolescentYoung AdultMaleFemaleAdultTreatment OutcomeAsparaginase

Stichwörter der Autor:innen

AYAAcute lymphoblastic leukemiaAsparaginaseLow-and-middle income countriesSurvival

Substanzen

Asparaginase

Autor:innen und Institutionen

  • Hematology and Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Hematology and Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. Electronic address: roberta.demichelisg@incmnsz.mx.

Zitieren

APA

Ontiveros, J. L., & Demichelis-Gómez, R. (2026). SOHO State of the Art Updates and Next Questions | Success of a Modified Adolescent and Young Adult Treatment for Acute Lymphoblastic Leukemia in Mexico. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2025.10.012

Vancouver

Ontiveros JL, Demichelis-Gómez R. SOHO State of the Art Updates and Next Questions | Success of a Modified Adolescent and Young Adult Treatment for Acute Lymphoblastic Leukemia in Mexico. Clinical Lymphoma Myeloma and Leukemia. 2026. doi:10.1016/j.clml.2025.10.012

BibTeX
@article{Ontiveros2026,
  author = {Ontiveros, Juan Luis and Demichelis-Gómez, Roberta},
  title = {SOHO State of the Art Updates and Next Questions | Success of a Modified Adolescent and Young Adult Treatment for Acute Lymphoblastic Leukemia in Mexico},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  year = {2026},
  doi = {10.1016/j.clml.2025.10.012}
}
Kostenlos starten →